Table: begin end state 1 28 cytoplasmic 29 47 transmembrane 48 52 non-cytoplasmic 53 72 transmembrane 73 102 cytoplasmic 103 122 transmembrane 123 141 non-cytoplasmic 142 159 transmembrane 160 168 cytoplasmic 169 189 transmembrane 190 208 non-cytoplasmic 209 232 transmembrane 233 251 cytoplasmic 252 273 transmembrane 274 298 non-cytoplasmic 299 317 transmembrane 318 345 cytoplasmic 346 364 transmembrane 365 368 non-cytoplasmic 369 370 transmembrane 371 374 non-cytoplasmic 375 393 transmembrane 394 405 cytoplasmic 406 427 transmembrane 428 428 non-cytoplasmic
Input: >GFF1000 FitnessBrowser__WCS417:GFF1000 MTDVRTPAAENPAATTTVTTGWTQYDTTWMLGLYGTAIGAGTLFLPINAGVGGFWPLIVL ALLAFPMTFFAHRGLTRFVLSGKSGDITEVVEEHFGVGAGKLITLLYFFAIFPILLVYSV ALTNTLGSFMEHQLHMTPPPRAILSLVLILGLMAIVRCGQGVIVKAMSVLVYPFVASLLL LAFSLIPNWNGAFFASAGDGMPMPLFFKTLWLAIPVMVFSFNHSPIISAFAVDQKRVYGA QAERKSSGILATAHGMMVLTVMFFCFSCVLALSPADLAAAKAQNISILSYLANHFQTPVI AYAAPLIALVAITKSFLGHYIGASEGFQGLIVKSLRGRNRSMSAKWLERCTALFMVLTCW AVATFNPSILRMIETMGGPIIACLLFLMPMYAIRRVPSLRKYSGQVSNVFVVVIGLIALS AIVFSVLP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server